Home Tags TROPION-Breast02

Tag: TROPION-Breast02

Datopotamab Deruxtecan + Durvalumab Shows Robust and Durable Tumor Responses in...

Updated results from the BEGONIA phase 1b/2 trial for the cohort of patients treated with datopotamab deruxtecan + durvalumab (Imfinzi®; AstraZeneca;  Arm 7) showed that the treatment combination demonstrated durable tumor responses without  new safety signals in patients with previously untreated advanced or metastatic triple negative breast cancer (mTNBC) with six months additional follow-up from the previous data cut-off.